bpc-157 safety human study case report The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and BPC-157: What the Science Actually

At the maintenance dose of 2.4mg, it lasts barely two weeks

People with the following should discuss risks carefully with a medical professional: Liver disease Kidney disease Pernicious anemia Known allergies to any ingredient in the formulation Pregnancy or breastfeeding (safety not well-studied avoid unless prescribed) Because ingredients differ between providers, always verify the formulation and follow prescribed dosing to minimize risk

Lidocaine HCl Injection should also be used with caution in patients with impaired cardiovascular function since they may be less able to compensate for functional changes associated with the prolongation of A-V conduction produced by these drugs

[DOI] [PubMed] [Google Scholar] 42.Bilic M, Bumber Z, Blagaic AB, Batelja L, Seiwerth S, Sikiric P